clofibrate has been researched along with oxazoles in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kobayakawa, T; Osuga, K; Yasuda, H | 1 |
Bloxham, DP; Bradshaw, D; Cashin, CH; Dodge, BB; Lewis, EJ; Self, CR; Westmacott, D | 1 |
Maeda, S; Matsumoto, K; Mori, T; Moriya, T; Takabe, S; Takashima, K; Takeyama, S | 1 |
Parkinson, TM; Schultz, JR; Schurr, PE | 1 |
Azuma, YT; Morioka, A; Nakajima, H; Nishiyama, K; Takeuchi, T | 1 |
Campos, CR; Cannon, RE; Chan, GN; Evans, RA; Miller, DS; More, VR; Oliver, KD | 1 |
Jiao, S; Li, Q; Pan, M; Qu, J; Reinach, PS; Srinivasalu, N; Yan, J; Yang, Y; Zhou, X | 1 |
7 other study(ies) available for clofibrate and oxazoles
Article | Year |
---|---|
Experimental hyper-beta-lipoproteinemia and its amelioration by a novel hypolipidemic agent.
Topics: Animals; Cholesterol; Cholesterol, Dietary; Clofibrate; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Oxazoles; Propylthiouracil; Rats; Triglycerides | 1978 |
Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Bone and Bones; Clofibrate; Dinoprostone; Drug Evaluation, Preclinical; Female; Guinea Pigs; Male; Microbial Collagenase; Oxazoles; Rabbits; Rats | 1990 |
Synthesis and hypolipidemic activities of 5-thienyl-4-oxazoleacetic acid derivatives.
Topics: Animals; Anticholesteremic Agents; Clofibrate; Hypolipidemic Agents; In Vitro Techniques; Lethal Dose 50; Male; Oxazoles; Platelet Aggregation; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Triglycerides | 1986 |
Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs.
Topics: Animals; Carboxylic Acids; Cholesterol; Clofibrate; Disease Models, Animal; Fasting; Hyperlipidemias; Hypolipidemic Agents; Injections, Intraperitoneal; Injections, Intravenous; Kinetics; Male; Naphthalenes; Nicotinic Acids; Oxazoles; Phenols; Polysaccharides; Pyrrolidines; Rats; Surface-Active Agents; Thyroxine; Triglycerides; Triparanol | 1972 |
Clofibrate relaxes the longitudinal smooth muscle of the mouse distal colon through calcium-mediated desensitisation of contractile machinery.
Topics: Anilides; Animals; Anticholesteremic Agents; Benzamides; Calcium; Clofibrate; Colon; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Drug Evaluation, Preclinical; Guanylate Cyclase; Male; Marine Toxins; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Myosin-Light-Chain Phosphatase; Nitric Oxide Synthase; Oxazoles; Potassium Channel Blockers; PPAR alpha; Pyridines; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Sodium Channel Blockers; Soluble Guanylyl Cyclase | 2011 |
PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.
Topics: Alkanesulfonic Acids; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Blood-Brain Barrier; Brain; Capillaries; Clofibrate; Fasting; Fluorocarbons; Gene Expression Regulation; Linoleic Acid; Male; Mice, Inbred C57BL; Mice, Knockout; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Oxazoles; PPAR alpha; Rats, Sprague-Dawley; Tyrosine | 2017 |
Opposing Effects of PPARα Agonism and Antagonism on Refractive Development and Form Deprivation Myopia in Guinea Pigs.
Topics: Animals; Apolipoprotein A-II; Bezafibrate; Biometry; Blotting, Western; Butyrates; Clofibrate; Collagen Type I; Disease Models, Animal; Electroretinography; Fluorescent Antibody Technique, Indirect; Guinea Pigs; Intraocular Pressure; Malate Dehydrogenase; Myopia; Oxazoles; Phenylurea Compounds; PPAR alpha; Refraction, Ocular; Sensory Deprivation; Tyrosine | 2018 |